1 | hundred | 11,468 |
2 | thousand | 863 |
3 | hundred-fifty | 5 |
4 | icodextrin-containing | 5 |
5 | hundred-eighty | 4 |
6 | hundred-three | 4 |
7 | buspirone-treated | 3 |
8 | mt/ | 3 |
9 | order-of-magnitude | 3 |
10 | bin-to-bin | 2 |
11 | calyce | 2 |
12 | cus₃ | 2 |
13 | escitalopram- | 2 |
14 | hunderd | 2 |
15 | hundread | 2 |
16 | hundred-four | 2 |
17 | hundred-seven | 2 |
18 | hundred-six | 2 |
19 | hundred-sixty | 2 |
20 | non-afr | 2 |
21 | non-probiotic | 2 |
22 | nucleoside-analogues | 2 |
23 | two-unit | 2 |
24 | urinometers | 2 |
25 | 1,3,4-thiadiazolium-2-aminide | 1 |
26 | 12-residue | 1 |
27 | 14-17-year-old | 1 |
28 | 16/12.5 | 1 |
29 | 200-cgy | 1 |
30 | 3,8″-linked | 1 |
31 | 40/25-mg | 1 |
32 | 5-d. | 1 |
33 | 8-substituted | 1 |
34 | abfrontal | 1 |
35 | across-mode | 1 |
36 | ad5-infected | 1 |
37 | alcoholic-cirrhotic | 1 |
38 | amoxapine-treated | 1 |
39 | amyloidosis- | 1 |
40 | benzylisoquinolines | 1 |
41 | biofungicides | 1 |
42 | bispebs | 1 |
43 | body-stuffer | 1 |
44 | c-ldl-c. | 1 |
45 | cas-based | 1 |
46 | case-control- | 1 |
47 | cbt-e. | 1 |
48 | centi-morgan | 1 |
49 | challenge.in | 1 |
50 | cis-phosphines | 1 |
51 | co-investigated | 1 |
52 | conceptuses-all | 1 |
53 | cue-syllables | 1 |
54 | definitudes | 1 |
55 | demand-reducing | 1 |
56 | direction-are | 1 |
57 | dred | 1 |
58 | email/month | 1 |
59 | exponentials | 1 |
60 | fatfolds | 1 |
61 | female/one | 1 |
62 | flavonol-3-biosides | 1 |
63 | flupirtine-exposed | 1 |
64 | fractions-plasma | 1 |
65 | groups-obese | 1 |
66 | groups:34 | 1 |
67 | halons | 1 |
68 | handsearchers | 1 |
69 | hemofiltrations | 1 |
70 | hexachlorcyclohexanes | 1 |
71 | hh-responsive | 1 |
72 | hudnred | 1 |
73 | hun- | 1 |
74 | hundered | 1 |
75 | hundred-and | 1 |
76 | hundred-and-twelve | 1 |
77 | hundred-eleven | 1 |
78 | hundred-forty | 1 |
79 | hundred-seventy | 1 |
80 | hundred-twenty | 1 |
81 | hyperinflators | 1 |
82 | hypernephroma | 1 |
83 | implants-significantly | 1 |
84 | kaempferol- | 1 |
85 | lake-island | 1 |
86 | lettuces | 1 |
87 | ltx- | 1 |
88 | male/three | 1 |
89 | maropitant- | 1 |
90 | men/eight | 1 |
91 | mopan | 1 |
92 | non-mexican-american | 1 |
93 | non-obligatorily | 1 |
94 | non-serotypeable | 1 |
95 | non-stx | 1 |
96 | nonprostatitis | 1 |
97 | o-acyl- | 1 |
98 | o56 | 1 |
99 | observers-using | 1 |
100 | opioids-fentanyl | 1 |
101 | oxygen-vacancy-containing | 1 |
102 | p-aminohippurate- | 1 |
103 | pediatric-to | 1 |
104 | personas | 1 |
105 | phases-baseline | 1 |
106 | poct-positive | 1 |
107 | podoviruses | 1 |
108 | rad51-dependent | 1 |
109 | rumen- | 1 |
110 | se-unsupplemented | 1 |
111 | sesame-induced | 1 |
112 | side-rooms | 1 |
113 | stimuli-menthol | 1 |
114 | studies,130 | 1 |
115 | studies-529 | 1 |
116 | sub-scale/dimensions | 1 |
117 | subgenomes | 1 |
118 | subgroups-verum | 1 |
119 | textiloma | 1 |
120 | tfs- | 1 |
121 | thousand-one | 1 |
122 | tp1- | 1 |
123 | trials,184 | 1 |
124 | u74006f- | 1 |
125 | ush1c | 1 |
126 | varenicline-group | 1 |
127 | vha-owned | 1 |
128 | visit/week | 1 |
129 | widely-cultivated | 1 |
130 | women/seven | 1 |
131 | wooler-kay | 1 |
132 | xp-f | 1 |
133 | youth-clubs | 1 |
1 | 1,3,4-thiadiazolium-2-aminide | 1 |
2 | 12-residue | 1 |
3 | 14-17-year-old | 1 |
4 | 16/12.5 | 1 |
5 | 200-cgy | 1 |
6 | 3,8″-linked | 1 |
7 | 40/25-mg | 1 |
8 | 5-d. | 1 |
9 | 8-substituted | 1 |
10 | abfrontal | 1 |
11 | across-mode | 1 |
12 | ad5-infected | 1 |
13 | alcoholic-cirrhotic | 1 |
14 | amoxapine-treated | 1 |
15 | amyloidosis- | 1 |
16 | benzylisoquinolines | 1 |
17 | bin-to-bin | 2 |
18 | biofungicides | 1 |
19 | bispebs | 1 |
20 | body-stuffer | 1 |
21 | buspirone-treated | 3 |
22 | c-ldl-c. | 1 |
23 | calyce | 2 |
24 | cas-based | 1 |
25 | case-control- | 1 |
26 | cbt-e. | 1 |
27 | centi-morgan | 1 |
28 | challenge.in | 1 |
29 | cis-phosphines | 1 |
30 | co-investigated | 1 |
31 | conceptuses-all | 1 |
32 | cue-syllables | 1 |
33 | cus₃ | 2 |
34 | definitudes | 1 |
35 | demand-reducing | 1 |
36 | direction-are | 1 |
37 | dred | 1 |
38 | email/month | 1 |
39 | escitalopram- | 2 |
40 | exponentials | 1 |
41 | fatfolds | 1 |
42 | female/one | 1 |
43 | flavonol-3-biosides | 1 |
44 | flupirtine-exposed | 1 |
45 | fractions-plasma | 1 |
46 | groups-obese | 1 |
47 | groups:34 | 1 |
48 | halons | 1 |
49 | handsearchers | 1 |
50 | hemofiltrations | 1 |
51 | hexachlorcyclohexanes | 1 |
52 | hh-responsive | 1 |
53 | hudnred | 1 |
54 | hun- | 1 |
55 | hunderd | 2 |
56 | hundered | 1 |
57 | hundread | 2 |
58 | hundred | 11,468 |
59 | hundred-and | 1 |
60 | hundred-and-twelve | 1 |
61 | hundred-eighty | 4 |
62 | hundred-eleven | 1 |
63 | hundred-fifty | 5 |
64 | hundred-forty | 1 |
65 | hundred-four | 2 |
66 | hundred-seven | 2 |
67 | hundred-seventy | 1 |
68 | hundred-six | 2 |
69 | hundred-sixty | 2 |
70 | hundred-three | 4 |
71 | hundred-twenty | 1 |
72 | hyperinflators | 1 |
73 | hypernephroma | 1 |
74 | icodextrin-containing | 5 |
75 | implants-significantly | 1 |
76 | kaempferol- | 1 |
77 | lake-island | 1 |
78 | lettuces | 1 |
79 | ltx- | 1 |
80 | male/three | 1 |
81 | maropitant- | 1 |
82 | men/eight | 1 |
83 | mopan | 1 |
84 | mt/ | 3 |
85 | non-afr | 2 |
86 | non-mexican-american | 1 |
87 | non-obligatorily | 1 |
88 | non-probiotic | 2 |
89 | non-serotypeable | 1 |
90 | non-stx | 1 |
91 | nonprostatitis | 1 |
92 | nucleoside-analogues | 2 |
93 | o-acyl- | 1 |
94 | o56 | 1 |
95 | observers-using | 1 |
96 | opioids-fentanyl | 1 |
97 | order-of-magnitude | 3 |
98 | oxygen-vacancy-containing | 1 |
99 | p-aminohippurate- | 1 |
100 | pediatric-to | 1 |
101 | personas | 1 |
102 | phases-baseline | 1 |
103 | poct-positive | 1 |
104 | podoviruses | 1 |
105 | rad51-dependent | 1 |
106 | rumen- | 1 |
107 | se-unsupplemented | 1 |
108 | sesame-induced | 1 |
109 | side-rooms | 1 |
110 | stimuli-menthol | 1 |
111 | studies,130 | 1 |
112 | studies-529 | 1 |
113 | sub-scale/dimensions | 1 |
114 | subgenomes | 1 |
115 | subgroups-verum | 1 |
116 | textiloma | 1 |
117 | tfs- | 1 |
118 | thousand | 863 |
119 | thousand-one | 1 |
120 | tp1- | 1 |
121 | trials,184 | 1 |
122 | two-unit | 2 |
123 | u74006f- | 1 |
124 | urinometers | 2 |
125 | ush1c | 1 |
126 | varenicline-group | 1 |
127 | vha-owned | 1 |
128 | visit/week | 1 |
129 | widely-cultivated | 1 |
130 | women/seven | 1 |
131 | wooler-kay | 1 |
132 | xp-f | 1 |
133 | youth-clubs | 1 |
1 | tp1- | 1 |
2 | p-aminohippurate- | 1 |
3 | u74006f- | 1 |
4 | kaempferol- | 1 |
5 | case-control- | 1 |
6 | o-acyl- | 1 |
7 | escitalopram- | 2 |
8 | rumen- | 1 |
9 | hun- | 1 |
10 | tfs- | 1 |
11 | amyloidosis- | 1 |
12 | maropitant- | 1 |
13 | ltx- | 1 |
14 | c-ldl-c. | 1 |
15 | 5-d. | 1 |
16 | cbt-e. | 1 |
17 | mt/ | 3 |
18 | studies,130 | 1 |
19 | groups:34 | 1 |
20 | trials,184 | 1 |
21 | 16/12.5 | 1 |
22 | o56 | 1 |
23 | studies-529 | 1 |
24 | textiloma | 1 |
25 | hypernephroma | 1 |
26 | fractions-plasma | 1 |
27 | ush1c | 1 |
28 | alcoholic-cirrhotic | 1 |
29 | non-probiotic | 2 |
30 | hundread | 2 |
31 | sesame-induced | 1 |
32 | 3,8″-linked | 1 |
33 | vha-owned | 1 |
34 | dred | 1 |
35 | hundred | 11,468 |
36 | hundered | 1 |
37 | hudnred | 1 |
38 | cas-based | 1 |
39 | flupirtine-exposed | 1 |
40 | amoxapine-treated | 1 |
41 | buspirone-treated | 3 |
42 | co-investigated | 1 |
43 | widely-cultivated | 1 |
44 | ad5-infected | 1 |
45 | se-unsupplemented | 1 |
46 | 8-substituted | 1 |
47 | 14-17-year-old | 1 |
48 | hundred-and | 1 |
49 | lake-island | 1 |
50 | thousand | 863 |
51 | hunderd | 2 |
52 | calyce | 2 |
53 | 1,3,4-thiadiazolium-2-aminide | 1 |
54 | across-mode | 1 |
55 | order-of-magnitude | 3 |
56 | hundred-three | 4 |
57 | male/three | 1 |
58 | non-serotypeable | 1 |
59 | phases-baseline | 1 |
60 | thousand-one | 1 |
61 | female/one | 1 |
62 | direction-are | 1 |
63 | groups-obese | 1 |
64 | 12-residue | 1 |
65 | hh-responsive | 1 |
66 | poct-positive | 1 |
67 | hundred-and-twelve | 1 |
68 | xp-f | 1 |
69 | 40/25-mg | 1 |
70 | demand-reducing | 1 |
71 | icodextrin-containing | 5 |
72 | oxygen-vacancy-containing | 1 |
73 | observers-using | 1 |
74 | email/month | 1 |
75 | visit/week | 1 |
76 | abfrontal | 1 |
77 | conceptuses-all | 1 |
78 | stimuli-menthol | 1 |
79 | opioids-fentanyl | 1 |
80 | subgroups-verum | 1 |
81 | non-mexican-american | 1 |
82 | centi-morgan | 1 |
83 | mopan | 1 |
84 | hundred-eleven | 1 |
85 | hundred-seven | 2 |
86 | women/seven | 1 |
87 | challenge.in | 1 |
88 | bin-to-bin | 2 |
89 | pediatric-to | 1 |
90 | varenicline-group | 1 |
91 | body-stuffer | 1 |
92 | non-afr | 2 |
93 | hundred-four | 2 |
94 | personas | 1 |
95 | bispebs | 1 |
96 | youth-clubs | 1 |
97 | fatfolds | 1 |
98 | lettuces | 1 |
99 | biofungicides | 1 |
100 | flavonol-3-biosides | 1 |
101 | definitudes | 1 |
102 | cue-syllables | 1 |
103 | subgenomes | 1 |
104 | hexachlorcyclohexanes | 1 |
105 | cis-phosphines | 1 |
106 | benzylisoquinolines | 1 |
107 | podoviruses | 1 |
108 | nucleoside-analogues | 2 |
109 | nonprostatitis | 1 |
110 | exponentials | 1 |
111 | side-rooms | 1 |
112 | sub-scale/dimensions | 1 |
113 | hemofiltrations | 1 |
114 | halons | 1 |
115 | handsearchers | 1 |
116 | urinometers | 2 |
117 | hyperinflators | 1 |
118 | men/eight | 1 |
119 | two-unit | 2 |
120 | rad51-dependent | 1 |
121 | hundred-six | 2 |
122 | non-stx | 1 |
123 | wooler-kay | 1 |
124 | 200-cgy | 1 |
125 | non-obligatorily | 1 |
126 | implants-significantly | 1 |
127 | hundred-fifty | 5 |
128 | hundred-eighty | 4 |
129 | hundred-seventy | 1 |
130 | hundred-twenty | 1 |
131 | hundred-forty | 1 |
132 | hundred-sixty | 2 |
133 | cus₃ | 2 |